Skip to content
Ethionamide Tablets

Ethionamide Tablets

Ethionamide

Ethionamide tablets for tuberculosis. They are used when first-line TB drugs cannot be used or have not worked.

Category
Antibiotics
Active ingredient
Ethionamide
Route
Oral use
Form
Tablet
Strengths
250mg

The exact manufacturer offered is confirmed by the fulfilment partner before supply.

Prescription and consultation requirements for Ethionamide Tablets vary by destination and are determined by the fulfilment partner.

Ethionamide Tablets details

Condition
Tuberculosis
Alternative names
trecator
Therapeutic class
Isotonic Hydrazide Derivative
Pharmacological class
Antitubercular Agent
Contraindications
severe hepatic impairment; hypersensitivity to ethionamide
Minor side effects
nausea; vomiting; abdominal pain
Moderate side effects
diarrhoea; postural hypotension; elevated liver enzymes
Dosage forms
Tablet
Administration route
Oral use
Supply category
Prescription-only medicine (POM)
Onset Time
1–2 weeks
Duration
12–24 hours
Storage instructions
Store below 25°C.
Drug interactions
Isoniazid; Rifadin
Age restrictions
Approved for children and adults.
Serious side effects

severe hepatotoxicity, requires immediate medical attention; severe peripheral neuropathy, requires immediate medical attention

Patient summary

Ethionamide tablets for tuberculosis. They are used when first-line TB drugs cannot be used or have not worked.

Mechanism of action

Disrupts cellular mycolic acid synthesis in the mycobacterial cell wall, preventing growth and cellular division.

Pregnancy and breastfeeding

Pregnancy: Use if potential benefits outweigh risks. Breastfeeding: Consult a clinician.

What you will receive

Ethionamide Tablets is a generic medicine sold under the name of its active ingredient, Ethionamide, rather than under a brand.

  • The fulfilment partner confirms the offered manufacturer and product before supply.
  • Check the active ingredient, strength, form and pack shown at checkout before confirming an order.

How we compare medicine brands and generics